Literature DB >> 31949378

Tumor Thrombi in Multiple Tributaries of the Mesenteric Vein in a Case of Carcinoma Rectosigmoid: A Rare Entity.

Anurag Jain1, Harkirat Singh1, Amit Sharma1, Azhar Husain1.   

Abstract

Treatment for tumor thrombus in multiple blood vessels can be a challenge for management and thus FDG PET CT is a potent tool in evaluation of such cases in differentiating between bland and tumor thrombus and commenting on the extent of the involvement. Copyright:
© 2019 Indian Journal of Nuclear Medicine.

Entities:  

Keywords:  Carcinoma rectosigmoid; fluorodeoxyglucose positron emission tomography-computed tomography; hypermetabolic; mesenteric veins; tumor thrombi

Year:  2019        PMID: 31949378      PMCID: PMC6958949          DOI: 10.4103/ijnm.IJNM_143_19

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


A 67-year-old female patient with biopsy-proven carcinoma colon underwent contrast-enhanced computed tomography (CT) scan (contrast-enhanced CT) of the abdomen which showed, diffuse circumferential enhancing wall thickening of the sigmoid colon and proximal rectum associated with the inferior mesenteric vein thrombosis. Fluorodeoxyglucose positron emission tomography CT (FDG-PET CT) done for staging workup revealed metabolically active lesion in sigmoid colon and proximal rectum (site of primary lesion, maximum standardized uptake value-22.33) with FDG avid mesenteric and pericolic lymph nodes. Diffusely increased FDG uptake was seen in multiple mesenteric veins and its network along the involved segment of colon [Figure 1].
Figure 1

MIP image in coronal section, fused PET CT image in Coronal and axial section shows increased FDG uptake in the recto-sigmoid tumor and mesenteric vessels with tributaries like a network emanating from the tumor. Incidental detection of thyromegaly with diffusely increased FDG uptake is consistent with clinical thyroiditis

MIP image in coronal section, fused PET CT image in Coronal and axial section shows increased FDG uptake in the recto-sigmoid tumor and mesenteric vessels with tributaries like a network emanating from the tumor. Incidental detection of thyromegaly with diffusely increased FDG uptake is consistent with clinical thyroiditis Tumor extension into a vessel is called intravascular tumor thrombus and is a relatively rare complication of solid tumor. Malignancies showing more frequent incidence of tumor thrombus are renal cell carcinoma, Wilms tumor, adrenal cortical carcinoma and hepatocellular carcinoma with few sporadic cases reported for the diagnosis of tumor thrombosis by PET/CT. Its presence changes the stage, treatment, and prognosis. Venous tumor thrombus is a rare finding in colorectal cancer, seen only in only 1%–2% of cases. Due to dual venous drainage through the portal and internal iliac systems, tumor thrombus from rectal cancer can involve either the inferior mesenteric vein or the internal iliac veins.[12] As per the currently available literature, the most common site of tumor thrombus reported is inferior vena cava. The involvement of multiple mesenteric veins by tumor thrombus is not reported to the best of our knowledge.[3] Identifying tumor thrombus is a challenging task though it is crucial for management. Multi-modality imaging using ultrasound, color Doppler, computed tomography, magnetic resonance imaging, and FDG-PET CT plays an important role in this situation. Differentiating between bland and tumor thrombus is of utmost importance while evaluating a patient for staging of cancer or if incidental detection of thrombus is there. The conventional modalities have few nonspecific criteria to clinch the differentiation; however, FDG PET CT plays an integral role in to provide anatomical extent and metabolic details, thus confidently differentiate between bland and tumor thrombus.[4] Treatment options available for tumor thrombus are surgery, chemotherapy, interventional radiology, and anti-angiogenic agents. Medical management is the option for bland thrombus.[56] However, treatment for thrombus in multiple blood vessels can be a challenge for management, and thus FDG PET CT is a potent tool in the evaluation of such cases in differentiating between bland and tumor thrombus and commenting on the extent of the involvement.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.

Authors:  Zhi-Jie Niu; Yi-Long Ma; Ping Kang; Sheng-Qiu Ou; Zhi-Bin Meng; Zhi-Kun Li; Feng Qi; Chang Zhao
Journal:  Med Oncol       Date:  2011-12-27       Impact factor: 3.064

Review 2.  Multimodality Imaging of Tumour Thrombus.

Authors:  Saurabh Rohatgi; Stephanie A Howard; Sree Harsha Tirumani; Nikhil H Ramaiya; Katherine M Krajewski
Journal:  Can Assoc Radiol J       Date:  2015-02-03       Impact factor: 2.248

3.  18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?

Authors:  Punit Sharma; Rakesh Kumar; Sunil Jeph; Sellam Karunanithi; Niraj Naswa; Arun Gupta; Arun Malhotra
Journal:  Nucl Med Commun       Date:  2011-09       Impact factor: 1.690

Review 4.  Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.

Authors:  Samuel M Lawindy; Tony Kurian; Timothy Kim; Devanand Mangar; Paul A Armstrong; Angel E Alsina; Cedric Sheffield; Wade J Sexton; Philippe E Spiess
Journal:  BJU Int       Date:  2012-04-30       Impact factor: 5.588

Review 5.  Tumor thrombus: incidence, imaging, prognosis and treatment.

Authors:  Keith Bertram Quencer; Tamir Friedman; Rahul Sheth; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

6.  18F- FDG-PET/CT for the diagnosis of tumor thrombosis.

Authors:  Tima Davidson; Orly Goitein; Abraham Avigdor; S Tzila Zwas; Elinor Goshen
Journal:  Isr Med Assoc J       Date:  2009-02       Impact factor: 0.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.